Cover Image

Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario

Saved in:

Bibliographic Details
Main Authors:	Alexandra M. Franklyn (Author), Joseph K. Eibl (Author), Graham Gauthier (Author), David Pellegrini (Author), Nancy E. Lightfoot (Author), David C. Marsh (Author)
Format:	Book
Published:	BMC, 2017-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada
by: Kristen A. Morin, et al.
Published: (2019)

Correction to: Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada
by: Kristen A. Morin, et al.
Published: (2019)

A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health data
by: Kristen A. Morin, et al.
Published: (2020)

The opioid crisis: past, present and future policy climate in Ontario, Canada
by: Kristen A. Morin, et al.
Published: (2017)

Measuring treatment attrition at various stages of engagement in Opioid Agonist Treatment in Ontario Canada using a cascade of care framework
by: Farah Tahsin, et al.
Published: (2022)

Erratum: Evolution of benzodiazepine receptor agonist prescriptions in general practice: A registry-based study
by: Frontiers Production Office
Published: (2022)

Comparison of Five Benzodiazepine-Receptor Agonists on Buprenorphine-Induced µ-Opioid Receptor Regulation
by: Géraldine Poisnel, et al.
Published: (2009)

A study protocol for a quasi-experimental community trial evaluating the integration of indigenous healing practices and a harm reduction approach with principles of seeking safety in an indigenous residential treatment program in Northern Ontario
by: T. N. Marsh, et al.
Published: (2021)

Clinical Outcomes of Benzodiazepine Prescribing for People Receiving Opioid Agonist Treatment: A Systematic Review of the Evidence
by: Catriona Matheson, et al.
Published: (2024)

Community trial evaluating the integration of Indigenous healing practices and a harm reduction approach with principles of seeking safety in an Indigenous residential treatment program in northern Ontario
by: K. A. Morin, et al.
Published: (2022)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
by: Jørn Henrik Vold, et al.
Published: (2020)

A scoping review of motor vehicle operator performance assessments for benzodiazepine receptor agonists
by: Andrea L. Murphy, et al.
Published: (2024)

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment
by: Marchand Kirsten, et al.
Published: (2012)

Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study
by: Cayley Russell, et al.
Published: (2022)

Maternal Characteristics of Women Exposed to Hypnotic Benzodiazepine Receptor Agonist during Pregnancy
by: Bjarke Askaa, et al.
Published: (2014)

Evolution of benzodiazepine receptor agonist prescriptions in general practice: A registry-based study
by: Kristien Coteur, et al.
Published: (2022)

Anticonvulsant Effects of Aerial Parts of Extract in Mice: Involvement of Benzodiazepine and Opioid Receptors
by: Amir Rashidian PharmD, PhD, et al.
Published: (2017)

Anticonvulsant activity of Dorema ammoniacum gum: evidence for the involvement of benzodiazepines and opioid receptors
by: Manijeh Motevalian, et al.
Published: (2017)

Pharmacist-Led Deprescribing of Opioids and Benzodiazepines in Older Adults: Examining Implementation and Perceptions
by: Tamera D. Hughes, et al.
Published: (2024)

Anticonvulsant Effects of Aerial Parts of Extract in Mice: Involvement of Benzodiazepine and Opioid Receptors
by: Amir Rashidian PharmD, PhD, et al.
Published: (2017)

Opioid Antagonists: Will they Solve all of the Problems Associated with Opioid Agonists?
by: Adam M Kaye
Published: (2014)

The state of S100-positive glia and the effect on it on the GABA-benzodiazepine receptor agonist, carbacetam, in diabetic retinopathy
by: S. V. Ziablitsev, et al.
Published: (2024)

Concurrent Prescription Fills of Opioids and Benzodiazepines Among Postpartum Women During COVID-19
by: Amanda J. Abraham, PhD, et al.
Published: (2024)

Therapeutic Potential of Kappa Opioid Agonists
by: Tyler C. Beck, et al.
Published: (2019)

Applying the socio-ecological model to understand community reintegration experiences among individuals on opioid agonist treatment (OAT) released from federal incarceration in Ontario, Canada
by: Cayley Russell, et al.
Published: (2022)

Interim opioid agonist treatment for opioid addiction: a systematic review
by: Laura Samsó Jofra, et al.
Published: (2022)

Reducing long‐term use of benzodiazepine receptor agonists: In‐depth interview study with primary care stakeholders
by: Kristien Coteur, et al.
Published: (2024)

Trends in the use of benzodiazepine receptor agonists among working-age adults in Belgium from 2004 to 2018
by: Lisa Colman, et al.
Published: (2023)

Preliminary Investigation of Pharmacist-Delivered, Direct-to-Provider Interventions to Reduce Co-Prescribing of Opioids and Benzodiazepines among a Medicare Population
by: Jennifer M. Bingham, et al.
Published: (2020)

Anticonvulsant effects of aerial parts of <it>Passiflora incarnata </it>extract in mice: involvement of benzodiazepine and opioid receptors
by: Shariati-Rad Schwann, et al.
Published: (2007)

Association of Benzodiazepine Receptor Agonist Use With Changes in Psoriasis Severity in Adult Population: A Population-Based Study
by: Ke-Ting Pan, et al.
Published: (2021)

Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: A qualitative study of stakeholder groups
by: Perrine Evrard, et al.
Published: (2023)

Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: A nested case-control study
by: Abisola Olopoenia, et al.
Published: (2022)

Novel Kappa-Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus: Systematic Review
by: Adrian Joseph Michel Bailey, et al.
Published: (2022)

Integrating Social Determinants of Health and Laboratory Data: A Pilot Study To Evaluate Co-Use of Opioids and Benzodiazepines
by: Jill S. Warrington MD, PhD, et al.
Published: (2019)

Analysis of changes in trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs
by: Miguel Angel Fernández García, et al.
Published: (2018)

Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127
by: Yuki Moriya, et al.
Published: (2023)

Workplace System Factors of Obstetric Nurses in Northeastern Ontario, Canada: Using a Work Disability Prevention Approach
by: Behdin Nowrouzi, et al.
Published: (2015)

Education Environment and Role Transition of Internationally Educated Nurses Enrolled in a Practical Nursing Bridging Program in Ontario, Canada
by: Edward Cruz, et al.
Published: (2022)

Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment
by: Heather Palis, et al.
Published: (2021)